Effectiveness of the 23-Valent Pneumococcal Polysaccharide Vaccine Against Community-Acquired Pneumonia in the General Population Aged >=60 Years: 3 Years of Follow-up in the CAPAMIS Study - Concepedia

Concepedia

Publication | Closed Access

Effectiveness of the 23-Valent Pneumococcal Polysaccharide Vaccine Against Community-Acquired Pneumonia in the General Population Aged >=60 Years: 3 Years of Follow-up in the CAPAMIS Study

140

Citations

19

References

2014

Year

Olga Ochoa‐Gondar, Ángel Vila-Córcoles, Teresa Rodríguez-Blanco, Frederic Gómez‐Bertomeu, E. Figuerola‐Massana, Xavier Raga-Luria

Clinical Infectious Diseases

Abstract

Our data support a protective effect of recent PPV23 vaccination (within previous 5 years) against both pneumococcal and all-cause CAP.

References

	Year	Citations

Page 1